BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF MECHANICAL THROMBECTOMY WITH STENT RETRIEVERS AFTER THROMBOLYSIS IN ISCHEMIC-STROKE WITH LARGE VESSEL OCCLUSION IN THE CHILEAN PUBLIC SECTOR.

Author(s)

Lenz Alcayaga R1, Paredes D2, Hernández K3, Valencia JE4
1Universidad Nacional Andrés Bello, Lenz Consultores., Santiago, Chile, 2Universidad Andrés Bello, Universidad de Chile & Medtronic Cluster SOLA, Santiago, RM, Chile, 3Lenz Consultores, Independencia, RM, Chile, 4Medtronic, Miami, FL, USA

Objectives: Ischemic-Stroke (IS) is a prevalent disease, responsible for long-term disability, premature deaths, and high-expenditure in Chile. Available treatments for IS due to Large-Vessel Occlusion (LVO) are Thrombolysis (IV-tPA) and Mechanical Thrombectomy (MT) with stent retrievers. Despite its clinical benefits, MT is not covered in Chile. A Budget-Impact Analysis (BIA) was conducted to estimate the financial impact of adding MT after IV-TPA in Chile.

Methods: A BIA was carried-out based on a decision tree (5 year-horizon, from the public-payor perspective). The first scenario was defined by an inertial execution of MT for cases undergoing IV-tPA and potential candidates for MT. The second scenario considered a progressive expansion of MT based on international proportions of IV-tPA/MT (0.90). Sources of local costs were Related-Diagnosis Groups (DRGs) out of a sample of homogenous high-complexity public-providers (PP). Local overall-survival stats were applied to estimate the flows of cases leaving the model.

Results: The cost for MT -estimated from DRG for the case-mix of non-complicated (22.11%), with complications (47.37%), with major complications (26.32%), and with other IR-DRGs (4.22%)- was CLP$8,508,934.

For the first scenario, the historical growth of IV-tPA was projected on a linear-regression over a 5-year horizon (R2=0.8998). Furthermore, a proportion of 0.36 of IV-tPA/MT explored throughout DRGs was applied. For that case-mix, a total expenditure (TE), including complementary costs-drivers, of CLP$9,462MM would be reached by the fifth-year (82.28% corresponding to IV-tPA+MT only). MT accounts for 53.42% of the cost of IV-tPA+MT for all years. Regarding TE, MT accounts for 44.16% (less disability). In the second scenario, the TE in IS with LVO is projected to grow 1.85 times (CLP$20,198MM, of which 89.54% is expended in IV-tPA+MT).

Conclusion: When both scenarios are compared, the budget impact is CLP$10,735MM (2.13 times) by the fifth-year, enabling an expansion of 1,066 MT quotas versus the inertial scenario for IS with LVO.

Conference/Value in Health Info

2020-05, ISPOR 2020, Orlando, FL, USA

Value in Health, Volume 23, Issue 5, S1 (May 2020)

Code

PMD22

Topic

Economic Evaluation

Topic Subcategory

Budget Impact Analysis

Disease

Medical Devices, Neurological Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×